仙灵骨葆胶囊联合冲击波治疗下肢长骨骨不连的临床观察
本文选题:冲击波 + 仙灵骨葆胶囊 ; 参考:《福建中医药大学》2016年硕士论文
【摘要】:目的:观察仙灵骨葆胶囊联合冲击波治疗下肢长骨骨不连的临床疗效,为下肢长骨骨不连治疗提供临床依据。方法:纳入2014年2月至2015年2月期间在我院治疗的符合标准的60名下肢长骨骨不连患者,按入院时间先后顺序对应随机数字表,随机分为冲击波组和联合组(仙灵骨葆胶囊联合冲击波),每组30名患者。其中男性34例,女性26例,平均年龄为38.53±6.12(24-50岁),采用前瞻性研究方法。冲击波组采用冲击波治疗仪治疗,在骨不连区域骨折线上选3个点作为基准点,冲击治疗探头垂直治疗部位,每个冲击点1000次,避开内固定物侧治疗,同时避开大血管及神经密集区。胫骨冲击能量选择为3.5 bar,股骨冲击能量选择为4.0 bar,频率为6Hz,每周治疗一次,总共治疗4次。联合组在按冲击波治疗方法治疗的同时口服仙灵骨葆胶囊(0.5g/粒),一次3粒,一日2次。治疗时间为1个月。分别于治疗后的3个月、6个月、12个月时记录各组患者的VAS评分、患肢负重情况评分、X线骨痂Lane-Sandhu评分、骨不连愈合时间,于治疗后12个月记录不愈合数, 采用SPSS18.0软件进行统计学分析。结果:平均随访时间为12.5个月(12-14个月)。在随访期间内,冲击波组、仙灵骨葆胶囊联合冲击波组均无血管神经损伤等不良反应事件发生:其中共有3例患者采用冲击波治疗中出现轻微酸痛,适应一周后酸痛缓解,有5例患者口服仙灵骨葆胶囊出现便秘,予番泻叶10g泡服2次而缓解。治疗后3个月时冲击波组及仙灵骨葆胶囊联合冲击波组的VAS疼痛评分无统计学差异(P0.05),治疗后6个月及12个月两组的VAS疼痛评分均有统计学差异(P0.05)。冲击波组和仙灵骨葆胶囊联合冲击波组在治疗后3个月、6个月及12个月时患肢负重情况均有差异,仙灵骨葆胶囊联合冲击波组的患肢负重情况评分均优于冲击波组(P0.05)。仙灵骨葆胶囊联合冲击波组在治疗后3个月、6个月及12个月时骨痂生长均优于冲击波组(P0.05)。在治疗12个月后骨不连不愈合率方面冲击波组高于仙灵骨葆胶囊联合冲击波组(PO.05)。仙灵骨葆胶囊联合冲击波组在临床愈合时间优于冲击波组(PO.05)。结论:仙灵骨葆胶囊联合冲击波治疗下肢长骨骨不连患者,可以缓解患肢的疼痛,促进骨折的临床愈合,联合组的作用优于单纯使用冲击波组,因此,仙灵骨葆胶囊联合冲击波可作为治疗下肢长骨骨不连的一种治疗方法。
[Abstract]:Objective: to observe the clinical effect of Xianling Gubao capsule combined with shock wave in the treatment of lower extremity long bone nonunion and to provide clinical basis for the treatment of lower extremity long bone nonunion. Methods: from February 2014 to February 2015, 60 patients with lower extremity long bone nonunion who were treated in our hospital from February 2014 to February 2015 were included in a random digital table according to the order of admission time. They were randomly divided into shock wave group and combined group (Xianling Gubao capsule combined shock wave) with 30 patients in each group. There were 34 males and 26 females with an average age of 38.53 卤6.12 (24-50 years). The shock wave group was treated with shock wave therapy instrument. Three points were selected as reference points on fracture line of nonunion area. The perpendicular treatment site of shock therapy probe was used for 1000 times, avoiding internal fixation side treatment. At the same time avoid large vessels and nerve dense areas. The impact energy of tibia and femur was 3.5 bar. and 4.0 bar. the frequency was 6Hz. once a week for a total of 4 times. In the combined group, Xianling Gubao capsule (0.5g/) was taken orally at the same time as shock wave therapy, 3 capsules once a day, 2 times a day. The treatment time was 1 month. VAS scores, limb load scores and Lane-Sandhu score of callus were recorded at 3 months, 6 months and 12 months after treatment, respectively. The number of nonunion was recorded 12 months after treatment. SPSS 18.0 software was used for statistical analysis. Results: the average follow-up time was 12.5 months (12-14 months). During the follow-up period, there were no adverse events such as vascular and nerve injury in shock wave group, Xianling Gubao capsule combined shock wave group. Five patients with constipation were treated with 10 g Senna leaf and relieved by taking Xianling Gubao capsule. There was no significant difference in VAS pain score between the shock wave group and Xianling Gubao capsule combined shock wave group 3 months after treatment (P0.05), but there was significant difference in VAS pain score between the two groups at 6 months and 12 months after treatment (P0.05). There were significant differences between the shock wave group and the Xianling Gubao capsule combined shock wave group at 3 months, 6 months and 12 months after the treatment, and the score of the affected limb weight in the Xianling Gubao capsule combined shock wave group was better than that in the shock wave group (P0.05). The callus growth of Xianling Gubao capsule combined with shock wave group was better than that of shock wave group at 3 months, 6 months and 12 months after treatment (P0.05). After 12 months of treatment, the nonunion rate of bone nonunion in shock wave group was higher than that in Xianling Gubao capsule combined shock wave group (PO. 05). The healing time of Xianling Gubao capsule combined with shock wave group was better than that of shock wave group (PO. 05). Conclusion: the combination of Xianling Gubao capsule and shock wave can relieve the pain of the affected limb and promote the clinical healing of the fracture. The combined group is superior to the shock wave group. Xianling Gu Bao capsule combined with shock wave can be used as a treatment method for lower extremity bone nonunion.
【学位授予单位】:福建中医药大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R274.9
【相似文献】
相关期刊论文 前10条
1 吴晓光;;仙灵骨葆胶囊佐治骨折疗效观察[J];浙江中西医结合杂志;2006年07期
2 邵光湘;韩铭;韩琳;;仙灵骨葆胶囊治疗酒精性股骨头坏死的临床观察[J];中国中医骨伤科杂志;2006年S2期
3 杨毅恒;周艳莉;;仙灵骨葆胶囊致肝功能异常2例[J];药物不良反应杂志;2007年03期
4 裴冬萍;操银针;;仙灵骨葆胶囊致急性药物性肝损伤1例[J];肝脏;2009年06期
5 黄炜;刘子秋;;仙灵骨葆胶囊配合推拿治疗老年性骨质疏松症的疗效观察[J];微量元素与健康研究;2012年06期
6 金建义;;仙灵骨葆胶囊治疗原发性骨质疏松症的疗效观察[J];中国医药指南;2012年35期
7 徐明雄;杨红;胡建强;;仙灵骨葆胶囊治疗股骨头缺血性坏死疗效观察[J];中国中医骨伤科杂志;2007年12期
8 杨杰;王义生;;仙灵骨葆胶囊预防激素性股骨头坏死43例[J];郑州大学学报(医学版);2011年02期
9 倪惠珍;谢凯;;仙灵骨葆胶囊治疗老年男性骨质疏松症50例临床观察[J];中国医药导刊;2011年02期
10 胡逞颖;;仙灵骨葆胶囊治疗骨折24例的效果评估[J];中国药业;2013年10期
相关会议论文 前4条
1 冯希云;任文霞;王学杰;赵跃斌;李玮;杨晓燕;檀小珍;任艳杰;;仙灵骨葆胶囊治疗老年性骨质疏松症的安全性与有效性[A];中华医学会第七次全国骨质疏松和骨矿盐疾病学术会议论文汇编[C];2013年
2 厉月丹;;仙灵骨葆胶囊治疗绝经后骨质疏松症临床观察(摘要)[A];2006年浙江省骨质疏松与骨矿盐疾病防治学术年会论文汇编[C];2006年
3 罗敏;谭新;刘泽;刘海叶;邓伟民;;仙灵骨葆胶囊治疗老年男性骨质疏松症骨转换指标的对比分析[A];中华医学会第七次全国骨质疏松和骨矿盐疾病学术会议论文汇编[C];2013年
4 高国英;吴越;魏晓舒;倪艳娜;;HPLC/MS对仙灵骨葆胶囊含量测定方法的探讨[A];2006年全国药物质量分析学术研讨会——《药物分析杂志》第二届普析通用杯优秀论文评选颁奖会论文集[C];2006年
相关重要报纸文章 前4条
1 苏利川;贵州同济堂启动前瞻性研究[N];中华工商时报;2007年
2 本报记者 陈国东;品牌药企加紧产品二次开发[N];医药经济报;2007年
3 卢素仙;突破骨坏死防治世界难题[N];科技日报;2007年
4 记者 李琦琨;贵州启动名优特中药大品种打造计划[N];经济信息时报;2012年
相关硕士学位论文 前8条
1 何昊;仙灵骨葆胶囊联合密固达治疗老年性骨质疏松症的疗效观察[D];成都中医药大学;2015年
2 沈保磊;仙灵骨葆胶囊联合冲击波治疗下肢长骨骨不连的临床观察[D];福建中医药大学;2016年
3 李伟举;筋骨胶V⒍許OP患者血清OC及PINP水平影响的研究[D];广州中医药大学;2016年
4 白雪;仙灵骨葆胶囊对骨关节炎的疗效观察p[D];河北医科大学;2010年
5 王冬雪;中药对激素性股骨头坏死的预防性研究[D];北京中医药大学;2009年
6 汪海滨;活血壮骨汤治疗早期股骨头缺血性坏死的临床研究[D];南京中医药大学;2010年
7 王红江;骨刺消痛汤治疗膝关节骨性关节炎临床研究[D];山东中医药大学;2003年
8 敖亮;球囊扩张椎体后凸成形术联合仙灵骨葆对胸腰椎压缩性骨折近期疗效的观察[D];成都中医药大学;2014年
,本文编号:2055853
本文链接:https://www.wllwen.com/zhongyixuelunwen/2055853.html